A drug repurposing screen identifies hepatitis C antivirals as inhibitors of the SARS-CoV2 main protease. Baker JD, Uhrich RL, Kraemer GC, Love JE, et al. PLoS One 2021;16:e0245962.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Baker JD, Uhrich RL, Kraemer GC, Love JE, et al. A drug repurposing screen identifies hepatitis C antivirals as inhibitors of the SARS-CoV2 main protease. PLoS One 2021;16:e0245962.
PMID: 33524017